M. Pankert

发表

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

E. Vicaut, G. Rioufol, G. Lemesle, 2020, The Lancet.

Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.

P. Morange, M. Alessi, G. Bonnet, 2015, International journal of cardiology.

Impact of new P2Y12 blockers on platelet reactivity and clinical outcomes after acute coronary syndrome: Insight from a large single center registry

P. Morange, M. Alessi, G. Bonnet, 2014 .

Impact of newP 2 Y 12 blockers on platelet reactivity and clinical outcomes after acute coronary syndrome : Insight from a large single center registry

P. Morange, M. Alessi, G. Bonnet, 2014 .

A new approach: Left atrial appendage occlusion, as an alternative to anticoagulant, to treat patient who suffered of atrial fibrillation, acute coronary syndrome and clopidogrel resistance.

T. Cuisset, J. Bonnet, M. Pankert, 2016, International journal of cardiology.

Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.

G. Bonnet, T. Cuisset, J. Bonnet, 2016, Archives of cardiovascular diseases.

Unusual cause of hypoxemia in myocardial infarction: interventional management.

T. Cuisset, J. Bonnet, M. Pankert, 2014, International Journal of Cardiology.

Early versus delayed invasive strategy for intermediate‐ and high‐risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial

K. Baumstarck, G. Lemesle, Z. Boueri, 2018, Clinical cardiology.

Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment: The EARLY Randomized Trial.

K. Baumstarck, G. Lemesle, Z. Boueri, 2020, JACC. Cardiovascular interventions.

Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting.

A. Loundou, P. Morange, M. Alessi, 2014, The American journal of cardiology.

Effect of CYP2C19*2 and *17 genetic variants on platelet response to clopidogrel and prasugrel maintenance dose and relation to bleeding complications.

W. Cohen, P. Morange, M. Alessi, 2013, The American journal of cardiology.

Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome.

W. Cohen, P. Morange, M. Alessi, 2011, The American journal of cardiology.

Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).

A. Loundou, P. Morange, M. Alessi, 2013, JACC. Cardiovascular interventions.

Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.

P. Morange, M. Alessi, T. Cuisset, 2011, The American journal of cardiology.

Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison.

P. Morange, M. Alessi, G. Bonnet, 2013, International journal of cardiology.

Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.

P. Morange, M. Alessi, G. Bonnet, 2013, International journal of cardiology.

Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement.

É. Marijon, P. Leprince, B. Iung, 2019, Journal of the American College of Cardiology.

Chronic heart failure in heart transplant recipients: Presenting features and outcome.

M. Pankert, G. Habib, M. Lambert, 2016, Archives of cardiovascular diseases.

Usefulness of index of microcirculatory resistance to detect microvascular dysfunction as a potential mechanism of stress-induced cardiomyopathy (Tako-tsubo syndrome).

T. Cuisset, J. Bonnet, M. Pankert, 2011, International journal of cardiology.

Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel.

P. Morange, M. Alessi, G. Bonnet, 2014, International journal of cardiology.

Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndrome.

P. Morange, M. Alessi, G. Bonnet, 2014, International journal of cardiology.

A THROMBUS ON A JOURNEY: a massive thrombus in transit with cerebral, coronary and pulmonary embolization.

K. Moussa, M. Pankert, G. Habib, 2020, The Canadian journal of cardiology.

Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome.

P. Morange, M. Alessi, G. Bonnet, 2014, International journal of cardiology.

Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: the TRASA trial.

T. Cuisset, J. Bonnet, M. Pankert, 2011, Archives of cardiovascular diseases.

Synergy between pharmacological and mechanical reperfusion in ST-segment elevation myocardial infarction patients: 2011 update

T. Cuisset, M. Pankert, J. Quilici, 2011, Journal of cardiovascular medicine.

Role of Antiplatelet Therapy in Secondary Prevention of Acute Coronary Syndrome

T. Cuisset, M. Pankert, J. Quilici, 2012, Journal of Cardiovascular Translational Research.

High Radiation Exposure of the Imaging Specialist During Structural Heart Interventions With Echocardiographic Guidance.

N. Jaussaud, J. Deharo, T. Cuisset, 2017, JACC. Cardiovascular interventions.

Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.

P. Morange, M. Alessi, G. Bonnet, 2013, International journal of cardiology.

TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial.

G. Lemesle, G. Rangé, G. Cayla, 2020, American heart journal.

Transient right internal thoracic arterial graft kink related to respiratory movements: Documentation of its existence, relevance and proposed management

J. Tardif, M. Pankert, P. L'Allier, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

How should I treat refractory cardiogenic shock in a patient with chronic biventricular heart failure and mitral regurgitation with difficult valve characteristics?

S. Kische, H. Ince, J. Bonnet, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Safety and effectiveness of the association ezetimibe-statin (E-S) versus high dose rosuvastatin after acute coronary syndrome: the SAFE-ES study.

P. Morange, M. Alessi, G. Bonnet, 2014, Annales de cardiologie et d'angeiologie.

Early versus delayed invasive strategy for intermediate‐ and high‐risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial

K. Baumstarck, G. Lemesle, Z. Boueri, 2018, Clinical cardiology.

Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement

É. Marijon, B. Iung, E. Belle, 2022 .